Southeastern Anatolia · Türkiye

Gastric Balloon in Gaziantep

With a population of approximately 2.1 million (TÜİK ADNKS 2024), Gaziantep is one of Southeastern Anatolia's leading industrial and gastronomy centers. Across Türkiye, obesity remains a prominent item on the national health agenda, with WHO 2022 modeling placing the rate at 32.1%. The Allurion Smart Capsule program is offered at 2 authorized clinics in Gaziantep.

15 min
Procedure Time
14.9%
Avg. Weight Loss*
2
Authorized Clinics

The Allurion Program in Gaziantep — Key Features

No Endoscopy

The procedure is completely non-invasive. The capsule is simply swallowed with water.

15 Minutes

Placement takes 15 minutes and you return home the same day.

Digital Tracking

Six months of expert support with a smart scale and mobile app.

Gaziantep: Southeastern Anatolia's industrial and gastronomy city

With a population of approximately 2.1 million (TÜİK ADNKS 2024), Gaziantep is one of the major cities of Southeastern Anatolia. Developed around the Şahinbey and Şehitkamil districts, the city sits at the center of neighboring provinces such as Kilis, Şanlıurfa, Adıyaman, Kahramanmaraş, Hatay, and Osmaniye, serving as a regional hub for healthcare and services.

Home to a deep-rooted industrial tradition, Gaziantep is known for its pace of manufacturing and trade. Alongside this, the city's rich and storied culinary culture is an inseparable part of daily life. While this vibrant gastronomy culture offers a delicious heritage, it can also be a factor that brings weight management and portion balance to the forefront for many people.

The intense work tempo typical of an industrial city, shift-based work schedules, and a bustling commercial life can limit the time available for regular eating habits and physical activity. These local factors can make a sustainable approach to weight management meaningful for those living in Gaziantep.

Weight management in Türkiye: the national picture

Weight management remains an important public health topic across Türkiye. According to TÜİK's Türkiye Health Survey 2022, the obesity rate (BMI ≥30) among the population aged 15 and over was measured at 20.2%; the rate is 23.6% among women and 16.8% among men.

In the WHO 2022 modeling, which uses a different methodology, Türkiye ranks among the countries with high obesity prevalence in the European Region at 32.1%. Because TÜİK's measurement-based data and WHO's model-based estimate rely on different methods, the two figures should be evaluated separately.

Since TÜİK does not publish obesity rates at the provincial or regional level, it would not be accurate to give a separate percentage for Gaziantep. However, local factors such as the city's industrial tempo, shift-based work schedules, sedentary working conditions, and deep-rooted culinary culture can be counted among the elements that bring weight management to the forefront for many people.

Healthcare infrastructure and clinic access

With Gaziantep University and its advanced healthcare institutions, Gaziantep is one of the leading medical centers of its region. The city has the infrastructure capacity to serve patients arriving from neighboring provinces as well, which makes access to weight management expertise easier.

The Allurion Smart Capsule program is consistent with the multidisciplinary approach adopted at Ministry of Health-approved obesity centers: physician evaluation, nutrition counseling, and behavioral support are carried out together. This holistic standard ensures the program is treated not merely as a device placement, but as a comprehensive process.

The Allurion Program is offered at 2 authorized clinics in Gaziantep and is accessible from the city's central districts. These local clinics are part of a network of 60+ authorized centers across Türkiye. Which clinic is appropriate, and your eligibility, are determined through a physician evaluation.

The Allurion Smart Capsule program: step by step

The program is a holistic approach that brings together the Allurion Smart Capsule, the smart scale, a mobile app, and a 6-month nutrition and behavior program. The capsule — a swallowable gastric balloon — is swallowed with a glass of water in a procedure that takes about 15 minutes; the placement requires no anesthesia, endoscopy, or surgery.

Once placed, the balloon is filled inside the stomach and helps support a feeling of fullness. At around week 16, the balloon empties on its own and passes naturally from the body; no separate removal procedure is needed. Throughout this period, progress is tracked via the mobile app and the smart scale, supported by the nutrition and behavior program.

In clinical studies, an average total body weight loss of 14.9% was reported within the program (Ienca et al., Obes Surg 2020, N=1,770, PMID 32279182). Results vary from person to person. The device was approved by the U.S. Food and Drug Administration (FDA) under full PMA Class III approval on February 23, 2026 (approval no. P250023). The program is generally intended for individuals aged 18 and over with a body mass index (BMI) of 27 or higher; definitive eligibility is determined through a physician evaluation.

Travel and the day of placement

Gaziantep Airport makes the city reachable by air, offering a practical option for visitors arriving from neighboring provinces as well. For people coming from surrounding provinces such as Kilis, Şanlıurfa, Adıyaman, Kahramanmaraş, Hatay, and Osmaniye, Gaziantep serves as a regional access point.

Because swallowing the capsule takes about 15 minutes and requires no anesthesia, the placement can typically be completed in a short clinic visit within the same day. Many people are able to travel home the same day after the placement; however, the process and follow-up plan are shaped by the physician's recommendations.

Since the nutrition and behavior program that follows the placement can also be supported remotely through the mobile app and the smart scale, the follow-up process is made easier for people arriving from other provinces. Even so, regular communication and check-ins are important for planning the program together with the clinic.

Gaziantep — Frequently Asked Questions

How many authorized clinics offer the Allurion Program in Gaziantep?

There are 2 authorized clinics offering the program in Gaziantep, and they are accessible from the city's central districts. These clinics are part of a network of 60+ authorized centers across Türkiye. Specific clinic information and eligibility are determined through a physician evaluation.

Is the program non-surgical?

Yes. The Allurion Smart Capsule is swallowed with a glass of water, and placement takes about 15 minutes. The procedure requires no anesthesia, endoscopy, or surgery.

How is the balloon removed?

At around week 16, the balloon empties on its own inside the stomach and passes naturally from the body. No separate removal procedure or additional intervention is needed.

Who is eligible for this program?

The program is generally intended for individuals aged 18 and over with a body mass index (BMI) of 27 or higher. Definitive eligibility is determined individually through a physician evaluation.

How much does the program cost in Gaziantep?

Pricing varies from clinic to clinic and may differ depending on the services included. For exact information, you should contact the relevant authorized clinic; no fixed price is stated here.

How much weight can be lost?

In clinical studies, an average total body weight loss of 14.9% was reported within the program (Ienca et al., Obes Surg 2020, N=1,770, PMID 32279182). Results vary from person to person.

How does the placement day work for people coming from neighboring provinces?

Thanks to Gaziantep Airport and the city's regional location, access is possible from provinces such as Kilis, Şanlıurfa, Adıyaman, Kahramanmaraş, Hatay, and Osmaniye. Because the placement is brief, many people are able to travel home the same day; the process and follow-up plan are shaped by the physician's recommendations.

Sources: TÜİK Türkiye Health Survey 2022; TÜİK ADNKS 2024; WHO 2022; Ienca et al., Obes Surg 2020 (PMID 32279182, N=1,770); FDA PMA P250023 (February 23, 2026). Results vary from person to person; this content is not a substitute for medical advice. Record date: June 2026.

Gaziantep: Free Assessment

Fill in the form and a specialist in the Gaziantep area will contact you.

Free Assessment

Let Our Specialists Call You

Let's evaluate together whether it's right for you.

HomeCitiesGaziantep

* Weight-loss figures are clinical group averages. Individual results may vary. Source: Ienca et al., Obes Surg 2020; PMID 32279182, N=1,770.

Book a Free Consultation